The PMCPA, U.K."s watchdog of the pharmaceutical market, is reprimanding Eli Lilly for promoting its anti-erectile dysfunction drug without presenting information on the side-effects or risks, and in a way that encourages patients to seek a prescription for Cialis (tadalafil) . Meanwhile Eli Lilly corrected its campaign last month.
저작권자 © 메디칼업저버 무단전재 및 재배포 금지